Optimising therapy in newly diagnosed metastatic Ewing sarcoma
Optimising tyrosine kinase inhibitor therapy in newly diagnosed metastatic Ewing sarcoma
We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Optimising tyrosine kinase inhibitor therapy in newly diagnosed metastatic Ewing sarcoma
Identifying drivers of central nervous system involvement in T-cell acute lymphoblastic leukaemia
ALLTogether1 CSF-FLOW Study
Understanding treatment decision-making processes in families where a child or young person has relapsed/refractory rhabdomyosarcoma
MG-fnRMS and CINSARC gene expression signatures to predict relapse in fusion gene negative rhabdomyosarcomas: assessing an approach to improve patient outcomes
Deciphering the genomic landscape of childhood refractory t-cell acute lymphoblastic leukaemia
An open label, single centre, single arm, prospective feasibility study evaluating the effectiveness of near-infrared fluorescence(NIRF)using indo-cyanine green(ICG)in intra-abdominal or intra-thoracic minimally invasive surgery(MIS)in paediatric oncology.
Living with treatment-related hearing loss: Experiences of survivors of childhood brain cancer
Towards chemotherapy-free treatment of paediatric post-transplant lymphoproliferative disorders